	US 11,717,556 B2
	Stemness-suppressing composition comprising OCT4 function-inhibiting peptide
Hyonchol Jang, Seoul (KR); Byung Il Lee, Goyang-si (KR); Hong-Duk Youn, Suwon-si (KR); and Bomin Song, Goyang-si (KR)
Assigned to NATIONAL CANCER CENTER, Goyang-si (KR)
Appl. No. 17/41,926
Filed by NATIONAL CANCER CENTER, Goyang-si (KR)
PCT Filed Mar. 5, 2019, PCT No. PCT/KR2019/002527 § 371(c)(1), (2) Date Sep. 25, 2020, PCT Pub. No. WO2019/190066, PCT Pub. Date Oct. 3, 2019.
Claims priority of application No. 10-2018-0035418 (KR), filed on Mar. 27, 2018; and application No. 10-2019-0024944 (KR), filed on Mar. 4, 2019.
Prior Publication US 2021/0069289 A1, Mar. 11, 2021
Int. Cl. A61K 38/16 (2006.01); A61P 35/00 (2006.01); A61K 35/28 (2015.01); A61K 38/08 (2019.01); A61K 38/10 (2006.01); A61K 45/06 (2006.01); G01N 33/574 (2006.01)

CPC A61K 38/16 (2013.01) [A61K 35/28 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); G01N 33/574 (2013.01)]

6 Claims

1. A method of treating cancer, the method comprising:

administering to an individual in need thereof an effective amount of a peptide consisting of one amino acid sequence selected from the group consisting of SEQ ID NOS: 5, 7, 9, 11, and 13.